The cited FiLM approach uses fluorescent intrabodies or nanobodies, while NASTIC analyzes localization trajectories. Neither establishes a requirement for a sy…
He aha ka mea i kūkulu maoli ʻia e nā mea noiʻi o ke Kulanui o Queensland?
Huahana PeptideʻO ka Hui Peptide maikaʻi loa Ua kūkulu ka hui ʻo Queensland i kahi kahua hōʻuluʻulu hōʻuluʻulu, ʻaʻole he microscope a ʻaʻole he ʻimi. NASTIC, pōkole no Nanoscale Spatiotemporal Indexing Clustering, lawe i ka ʻikepili localization hoʻokahi-molele a ʻike i nā nanoclusters mai nā trajectories nona nā pahu hoʻopaʻa i uhi ʻia i ka lewa a me ka manawa., me ka hoʻohana ʻana i nā ʻāpana paʻamau o r = 1.2 a me t = 20 s, a hōʻike pū ʻia nā radius puʻupuʻu, ola ana, ka helu hoʻokumu a me nā wahi wela (ka pepa hana NASTIC kumu, 2023).
Kalepa, noho ka paepae i loko o Accretion Bio, i hoʻokumu ʻia me Professor Frederic Meunier a me Dr Tristan Wallis o ka Queensland Brain Institute, kākoʻo ʻia e UniQuest a kākoʻo ʻia e Antler (ka hui ʻo Queensland Brain Institute, 2026). Mālama ka hoʻokuʻu ʻana i ka loulou maʻi maʻamau: pili ia i nā protein kī a me nā protein pili i ka maʻi, ʻAʻole inoa i ka protein kikoʻī a ʻaʻohe helu hoʻoholo. Mālama mākou i ka ʻatikala i kēlā pae kikoʻī.
He ʻoiaʻiʻo ke kaomi ma hope o kēia hana. A 2025 Hōʻike ka wānana Global Burden of Disease i ka maʻi maʻi o Parkinson 15.6 miliona iloko 2030, 20.4 miliona iloko 2040 a 25.2 miliona iloko 2050, a 112% ala mai 2021, alakaʻi nui ʻia e ka ʻelemakule o ka lehulehu (GBD 2021 hoʻonaʻauao kuhi, 2025).
No ke aha ka Probe, ʻAʻole ka Microscope, Hoʻopau i ka mea hiki iā ʻoe ke hoʻoholo
<papa helu ="blog-chart" kaila="laula-nui:640px;palena palena:1.5rem auto;nui-momona:12px;kiʻekiʻe laina:1.3;kala kala:hooilina"> <svg viewBox="0 0 560 380" kaila="laula-nui: 100%; kiekie: kaʻa; font-ohana: 'Inter', ʻōnaehana-ui, sans-serif; kala kala: #1e293b; --pakuhi-muted: #64748b;" kuleana="img" aria-labelledby="alzheimer-s-candidate-failure-by-phase-2002-2012-title alzheimer-s-candidate-failure-by-phase-2002-2012-desc"> <kaila> /* Hoʻokomo ka mea hāʻawi i ka pakuhi i loko o kahi iframe nona ka ʻeleʻele ʻeleʻele, a he ʻano ʻokoʻa ka iframe i ka pakuhi, no laila ua hōʻike ʻia nā pahu pahu leka me he mau papa ʻeleʻele a puni (prod 09-22). Akaka ka palapala i loko o ka iframe ma ka paʻamau; ʻO ka pena kiʻi ma ʻaneʻi e uhi ana i ke kāʻei o ka element, a ke kau ʻia ka pakuhi, ʻaʻohe mea pili kēia. E mālama i nā pale kihi ma waho o kēia poloka: ʻO kahi mea ʻano i loko o kahi SVG i hoʻokaʻawale ʻia ma ke ʻano he ʻike haole, no laila, hoʻolei kekahi bracket hele i kēlā me kēia lula i loko. */ html, kino { hope: #ffffff; palena palena: 0; } @media (makemake-hoemi-holo: hoemi) { * { hoʻouluulu: ʻaʻohe !mea nui; hoʻololi: ʻaʻohe !mea nui; } } </kaila> <pololei x="0" y="0" laula="560" kiekie="380" rx="8" hoʻopiha="#ffffff" /> <inoa id="alzheimer-s-candidate-failure-by-phase-2002-2012-title">ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae, 2002-2012</inoa> <wehewehe id="alzheimer-s-candidate-failure-by-phase-2002-2012-desc">ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae,, e like me ka manao mai ke kumu i oleloia. ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae, 2002-2012. ʻikepili pae pae: Māhele 1 72; Māhele 2 92; Māhele 3 98.Puna: Cummings, Morstorf & ʻO Zhong, Noi'i o Alzheimer & Lapaʻau 2014.</wehewehe> <kikokikona x="280.0" y="29" heleuma kikokikona="waena" font-size="18" font-kaumaha="800" hoʻopiha="kala kala">ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae, 2002-2012</kikokikona> <laina x1="145" y1="298.0" x2="510" y2="298.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="243.0" x2="510" y2="243.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="188.0" x2="510" y2="188.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="133.0" x2="510" y2="133.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="78.0" x2="510" y2="78.0" hahau ="kala kala" opacity="0.08" /> <kikokikona x="136.0" y="122.2" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Māhele 1</tspan></kikokikona> <pololei x="145" y="78.0" laula="268.2" kiekie="68.0" rx="4" hoʻopiha="#f97316" /> <kikokikona x="421.2" y="122.2" font-size="11" hoʻopiha="kala kala">72</kikokikona> <kikokikona x="136.0" y="198.2" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Māhele 2</tspan></kikokikona> <pololei x="145" y="154.0" laula="342.7" kiekie="68.0" rx="4" hoʻopiha="#38bdf8" /> <kikokikona x="495.7" y="198.2" font-size="11" hoʻopiha="kala kala">92</kikokikona> <kikokikona x="136.0" y="274.2" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Māhele 3</tspan></kikokikona> <pololei x="145" y="230.0" laula="365.0" kiekie="68.0" rx="4" hoʻopiha="#a78bfa" /> <kikokikona x="518.0" y="274.2" font-size="11" hoʻopiha="kala kala">98</kikokikona> <kikokikona x="280.0" y="366" heleuma kikokikona="waena" font-size="10" hoʻopiha="kā mākou(--pakuhi-muted, kala kala)">Puna: Cummings, Morstorf & ʻO Zhong, Noi'i o Alzheimer & ʻO ka lāʻau lapaʻau (2014)</kikokikona> </svg> </huahelu>
ʻO ka hana probe kekahi mea kōkua i ka hilinaʻi kiʻi, me ka optics, loaa, hoʻolālikelike, kūlana hāpana a me ka nānā ʻana. E noʻonoʻo i ke kaulahao ana piha ma mua o ka hana ʻana i ka ʻimi noiʻi ma ke ʻano he kumu palena wale nō.
Pili ka phototoxicity i ka nalu nalu, pāʻina, ʻano hoʻolaha, ʻano kelepona a me nā lepili. ʻAʻole hiki ke hoʻololi pololei i nā paepae o Vero-cell i nā neurons. E ana i ka viability a me ka hana kūpono ma lalo o nā kūlana kūʻai maoli; ʻaʻole hiki ke ʻike ʻia nā hopena i loko o kahi ākea i hōʻoia ʻia.
ʻO ka lepili ʻana i ka stoichiometry ka lua. ʻO ka hapa nui, ina aole pau, Hāʻawi nā hoʻolālā lepili i ka lepili substoichiometric, a hoʻolaha ʻia kahi degere ʻike maopopo ʻole o ka hōʻailona ʻana i kēlā me kēia kope-helu a i ʻole kiʻi koʻikoʻi i loaʻa mai ka fluorescence. (ka pepa lepili ProDOL, 2024). Inā ʻaʻole ʻoe i ʻike i ka nui o nā dyes e noho ana ma kēlā me kēia peptide, ʻAʻole hiki iā ʻoe ke hoʻololi i ka ikaika i nā mole.
ʻO wai nā ʻano hoʻololi Lepili-Kemika Hiki iā ʻoe ke kuhikuhi maoli?
Hiki iā ʻoe ke kuhikuhi piha i ke kemika lepili, a pono ʻoe, no ka mea, ʻaʻole hiki ke hoʻihoʻi ʻia mai ke kiʻi i hoʻopau ʻia. ʻO ke degere o ka hoʻopaʻa inoa ʻana he awelika e ana ʻia ma mua o ka manaʻo, a ʻo ka hana ProDOL e hōʻike ana he ʻokoʻa ia me ke kala, laina kelepona a me nā kūlana incubation (ka pepa lepili ProDOL, 2024).
No nā ʻimi peptide i hoʻopaʻa ʻia no ke kiʻi kiʻi ola-neuron, ʻO nā mea hoʻololi e hoʻololi i ke ana ʻo ia ka ʻike wai, lākiō wai-i-peptide, kahua hui, ka lōʻihi o ka loulou a me ke kemika, a pehea e wehe ʻia ai ke koena wai waihoʻoluʻu. Hoʻololi kēlā me kēia i ka mālamalama, kinai ʻana a i ʻole ka hope, a aia kēlā me kēia ma ka kikoʻī ma mua o ke kamaʻilio ʻana.
Hoʻololi
No ke aha ia e hoʻololi ai i ke ana
He aha e noi ai i ka mea hoʻolako e palapala
ʻIke ʻike wai
ʻO ka hauʻoli a me ka hoʻokuʻu, ʻokoʻa ka photostability a me ka hanauna ROS e ka wai
inoa kala, hailona, hauʻoli a me ka hoʻokuʻu maxima
Hoʻonui ka waihoʻoluʻu koena i ke kua a me ka hōʻailona punctate
Kaʻina hoʻomaʻemaʻe a me ka nānā ʻana i ka waihoʻoluʻu
Maʻemaʻe a me ka ʻike
ʻAʻole hōʻoia ka helu HPLC hoʻokahi i ka conjugate
Hana HPLC me LC-MS o ka conjugate
ʻO kā mākou hana hōʻailona peptide fluorescent e uhi i ka FITC, FAM, TAMRA, Cy3, Nā lepili Cy5 a me Cy7 me ka papa kuhikuhi hoʻololi ākea, me ka N-terminal acetylation, biotinylation, PEGylation, phosphorylation, cyclization a me nā lepili isotopic. He mea nui kēlā papa kuhikuhi ma ʻaneʻi no ka mea he hoʻoholo hoʻolālā ka pūnaewele conjugation, ʻaʻole he manaʻo hope.
Pehea ka maemae, ʻIkepili, Maʻiʻo, 'Oko'a ka Pa'a a me ka Ho'ā'o?
ʻElima mau nīnau kaʻawale, a ʻo ka palapala hōʻoia e pane i kekahi, ʻaʻole i pane i kekahi o nā mea ʻē aʻe. ʻO nā ʻāpana kikoʻī ma I Q6B helehelena kaawale, ʻike ʻike, ka maemae a me ka haumia, ka mana a me ka nui, me ke kūpaʻa e like me ke kumu no ka hoʻonohonoho ʻana i nā kikoʻī (1999). Nīnau ke alakaʻi like ʻana e kikoʻī loa nā hoʻāʻo ʻike i nā ʻano kūʻokoʻa o ke ʻano molekala, a me ka hoʻomaopopo ʻana he paʻakikī ka hoʻomaʻemaʻe piha ʻana a hilinaʻi nui i ke ʻano hana, no laila ua manaʻo ʻia ka maʻemaʻe mai ka hui pū ʻana o nā ʻano hana.
ʻO ia ka hoʻoponopono i ka maʻamau o ka ʻae ʻana i hoʻokahi helu HPLC ma ke ʻano he hailona. ʻAʻole helu ka wai a me nā paʻakai ka hoʻomaʻemaʻe peptide e HPLC, ka mea komo ole kokoke 220 nm, a ʻo ka helu maʻemaʻe kiʻekiʻe he liʻiliʻi me ka ʻike ʻole i hoʻopaʻa ʻia. ʻO ka hoʻāʻo analytical Orthogonal o nā peptides e pani i ke āpau: I Q2(R2) ʻae ʻia e hōʻike ʻia ka kikoʻī e kūʻē i kahi kaʻina hana orthogonal a paipai i ʻelua a ʻoi aku paha nā kaʻina hana inā ʻaʻole lawa kekahi (hāpai ʻia ʻo Nowemapa 2023). Ma ka hana, e hoʻopili i ka RP-HPLC me kahi kolamu i ʻōlelo ʻia, gradient a me ka loaʻa ʻana o ka nalu me LC-MS no ka ʻike a me kahi ʻike ʻike no ka peptide net.
Ma kahi e kākoʻo ai nā moʻolelo uila i ka hoʻouna i hoʻoponopono ʻia, 21 Mahele CFR 11 hoʻonohonoho i nā pae hoʻohālike e mālama ai ka FDA iā lākou ma ke ʻano he mea hilinaʻi a pono e palekana, nā ala hoʻokele manawa. E noi i ka ʻano peptide fluorescent e kapa inoa i kēlā me kēia ʻano, ʻaʻole hoʻokahi hopena.
ʻO wai nā mana e hiki ke pale aku i ka hoʻopiʻi hoʻopaʻa ʻana ma muli o ke kiʻi?
ʻAe ka mea loiloi i kahi koi hoʻopaʻa ʻana ke kāpae ʻia nā mana i ka mea hana reagent, ʻaʻole i ka wā e kū ana ke kiʻi. Hoʻonohonoho nā pae hoʻohālikelike no ka ʻimi kemikala i ka pa e pono ai ka ʻimi ponoʻī: ka mana ma lalo 100 nM i nā hoʻokolohua biochemical a ma lalo 1 µM i loko o nā pūnaewele, koho ʻoi aku ma mua o 30-fold i loko o ka ʻohana i manaʻo ʻia, a me nā hōʻike pololei o ke komo ʻana o ka pahuhopu i nā cell (ʻO ke au o nā ʻimi kemika kiʻekiʻe, 2022). Hoʻopaʻa ka loiloi like i ka nāwaliwali, ʻO nā pūhui koho ʻole i hoʻopuka i ka nui o nā manaʻo kuhi hewa i ka palapala, ʻo ia ke kumu o ka mana i hoʻonohonoho ʻia ma lalo nei ka ʻāpana o kahi pūʻolo a mākou e nīnau mua ai.
ʻO ke alakaʻi hōʻoia a ka Chemical Probes Portal e mālama i kahi reagent i hōʻailona ʻia ma ke ʻano he mea pono e hele ma ke ʻano he reagent ana a me kahi noiʻi kemika.: hōʻailona hilinaʻi pahuhopu ma lalo o nā kūlana hoʻāʻo, hoʻopaʻa ʻana i nā ʻike hiki ke hoʻohana, koho, a me kahi loulou mai ka hoʻopili ʻana i ka hana. ʻAʻole loaʻa kahi hōʻailona ʻālohilohi a i ʻole biologically active nona iho (Nā nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau kiʻi, 2021).
ʻO nā mana ʻelima a mākou e noi ai e ʻike
Hoʻohālikelike ʻia ka peptide ʻole i hōʻailona ʻia, ke kaʻina like a me ka hailona
ʻO ka peptide mana maikaʻi ʻole, ʻāwili a paʻa ʻole paha
ʻO nā lima kala wale a me ka lepili wale nō i ka manaʻo kūlike
Kūlana-ʻole a paʻa ʻole ke kūlana
Hōʻoia ʻo Orthogonal o ka hoʻopaʻa ʻana, kūʻokoʻa i ka fluorophore
E hoʻohana i nā mana i kūpono i ka koi a me ka ʻōlelo ʻana i nā mea ʻē aʻe i hoʻoholo ʻole ʻia. Hiki ke kaupalena ʻia ka hilinaʻi i ka mana i manaʻo ʻia, akā, ʻaʻole ia e hōʻemi i kēlā me kēia hopena i ka fluorescence nonspecific i ka wā e kamaʻilio ai nā hōʻike kūpono ʻē aʻe i ka maopopo ʻole.. Hoʻokumu PeptideM Peptides Mea Hana
He aha kēia e hoʻololi ai no nā papahana a Alzheimer a me Parkinson, a he aha kāu e wehewehe ai i ke kauoha ʻana?
Hoʻololi ia i ke kūlana hōʻike ma mua o ka ʻike, ʻaʻole ka biology maʻi. Ua loaʻa kahi helu helu ʻumi makahiki o nā hoʻāʻo o Alzheimer 244 nā pūhui i hoʻāʻo ʻia ma waena 2002 a 2012 me kekahi i aponoia, a 0.4% ka holomua holomua, a 72% o nā moho hāʻule i ka Phase 1, 92% i ka Phase 2 a 98% i ka Phase 3 (he ʻumi makahiki ka lōʻihi o ka helu ʻana o nā hoʻokolohua Alzheimer, 2014). Hana ʻia ka hapa nui o ka attrition ma mua o ka hale lapaʻau lohi, kahi pono kahi mechanistic, Pono e loaʻa i ka heluhelu ʻana i ke kelepona ola.
Ke kauoha ʻoe i kahi hōʻailona peptide probe no kēia hana, e kuhikuhi i ka pūʻolo, ʻaʻole wale ke kaʻina. E noi i ka pūnaewele conjugation a me ka loulou, ke ana ʻia ka lākiō dye-to-peptide me kona ʻano, LC-MS o ka conjugate, RP-HPLC me ke kolamu, i ʻōlelo ʻia ka gradient a me ka lōʻihi nalu, maʻiʻo peptide net, counterion a me ke koena TFA, he nānā hoʻoheheʻe i loko o kāu pale hoʻāʻo, a me kahi hōʻike paʻa.
Inā ʻo kou kūlana
A laila koi
E hoʻololi ʻia ka hōʻailona i ka helu kope
Ana ʻia ka dye-to-peptide ratio me ka mana hoʻopaʻa inoa
Holo ka Assay ma kahi kokoke i ka palena o ka hiki
ʻO ka maʻemaʻe conjugate i kākau ʻia a me ka ʻike, ʻaʻole hapa pākēneka wale nō
Loaʻa ka loaʻa ola lōʻihi a i ʻole
Ua hōʻike ʻia ka nui māmā a me ka mana phototoxicity
Hoʻopaʻa haʻawina nui-nui a i ʻole ka nui-pae
ʻO CoA kikoʻī nui me nā mea ʻike ala a me kahi ʻaoʻao paʻa
Manaʻo ʻia ka waiho ʻana i hoʻoponopono ʻia
Nā moʻolelo uila i hoʻopaʻa ʻia ma lalo 21 Mahele CFR 11
Hoʻokele ʻo MOL Changes i nā hui kūlohelohe a me nā hui ola i loko o ka hale, me ka pae paʻa, wai-wai a hui pū ʻia me ka microbial fermentation, a me ka hana ʻana mai ka milligram a hiki i ka paona kilo. No ka hana ʻimi noiʻi ʻo ia hoʻi ka hoʻololi, hiki ke kuhikuhi pū ʻia ka lepili fluorescent a me ka pūʻolo analytical, me ka hoʻāʻo pinepine ʻana ma kēlā me kēia kaʻina hana a me nā palapala kikoʻī he nui.
Nīnau pinepine
He kiʻi hoʻomaʻemaʻe HPLC kiʻekiʻe i lawa no ka hoʻokō ʻana i kahi ʻāpana noiʻi?
ʻAʻole. ʻO ka maʻemaʻe e hilinaʻi nui ʻia i ke ʻano a ua manaʻo ʻia e ka hui pū ʻana o nā ʻano hana (I Q6B, 1999). Wahi pakeneka ma 220 hoole nm ka wai a me ka paakai, no laila e hui pū me ka ʻike LC-MS a me kahi ʻike ʻike.
He aha kaʻu palapala e noi mua ai?
ʻO ka palapala hōʻoia kikoʻī kikoʻī o ka nānā ʻana me nā ʻano ʻike: kolamu, gradient, lōʻihi nalu, ʻO ke ʻano MS a me ka lakio hōʻailona. ʻAʻole hiki ke hana hou a pale ʻia paha kahi hopena me ka ʻole o kāna ʻano.
Ka hopena
He maʻalahi ka lula hoʻoholo a mākou e hoʻohana ai. E ʻae nui i ka wā e hōʻoia ʻia ai ka ʻike e ka mass spectrometry, hōʻike ʻia ka maʻemaʻe me kāna ʻano hana a hui pū ʻia me kahi ʻike ʻike, ana ʻia ka lākiō dye-to-peptide, loaʻa kahi mana hōʻailona-efficiency, a ua hōʻike ʻia ka nui māmā me ka nānā ʻana i ka phototoxicity. Hoole, a i ʻole e koho hou, ke nalowale kekahi o ia mau mea, no ka mea, e ʻike mau ana ke kiʻi.
Inā ʻoe e kūkulu nei i kahi papahana kiʻi kiʻi ola-neuron e pili ana i nā probes peptide i kapa ʻia, hiki i kā mākou hui ke hoʻohui i kahi pūʻolo hōʻoia hōʻoia a me kahi laʻana CoA kikoʻī e pili ana i kēia mau pae. E haʻi mai iā mākou i kāu kaʻina, lepili a me ka ho'āʻo hoʻopaʻa, a e haʻi mākou iā ʻoe i ka mea hiki a hiki ʻole ke kākoʻo i ka palapala.
Hōʻike ka mea hoʻopuka: Hāʻawi ʻo MOL Changes i nā lawelawe peptide a he hoihoi koʻikoʻi i kēia kumuhana. ʻO nā lālā lawelawe a me nā ʻōlelo hiki ke koi i nā mea hoʻolako; ʻO ka loaʻa a me ka hana ʻana no kahi kūkulu kikoʻī e koi i nā hōʻike kikoʻī o ka papahana.
Laau Laau Hou R&D ʻenehanaKaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.
Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.
🟢 Online · Pane i loko o 24h · Peptide Synthesis & CRO
MC
Aloha 👋 Welina mai iā MOL Changes
E haʻi mai iā mākou i kāu mea e pono ai - sequence, ka maemae, ka nui a i ʻole assay - a e pane kā mākou hui synthesis me kahi ʻōlelo kikoʻī i loko o hoʻokahi lā ʻoihana. ʻAʻole pono ka uku pūnaewele.